Solvent-Mediated Nonoriented Self-Aggregation Transformation: A Case Study of Gabapentin

被引:14
作者
Wu, Songgu [1 ,2 ]
Chen, Mingyang [1 ,2 ]
Rohani, Sohrab [3 ]
Zhang, Dejiang [1 ,2 ]
Du, Shichao [1 ,2 ]
Xu, Shijie [1 ,2 ]
Dong, WeiBing [1 ,2 ]
Gong, Junbo [1 ,2 ,4 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China
[2] Coinnovat Ctr Chem & Chem Engn Tianjin, Tianjin 300072, Peoples R China
[3] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada
[4] Tianjin Univ, Key Lab Modern Drug Delivery & High Efficiency Ti, Tianjin 300072, Peoples R China
基金
中国国家自然科学基金;
关键词
PHASE-TRANSFORMATION; SPHERICAL CRYSTALLIZATION; POLYMORPHIC TRANSFORMATION; CRYSTAL POLYMORPHISM; CALCIUM-CARBONATE; FORM II; NUCLEATION; INTERFACE; STABILITY; METHANOL;
D O I
10.1021/acs.cgd.7b00529
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A good powder performance is one of the essential targets for gabapentin (GBP). However, the low bulk density and flowability of GBP are still the industrial problems in practical production. The main purpose of this paper is to investigate the phase transformation of GBP from form I to form II in methanol, ethanol, propanol, acetone, acetonitrile, and ethyl acetate and improve the powder properties. The results suggested that there are two kinds of phase transformation mechanisms of GBP. One is the classic solvent mediated transformation in alcohols, and the other is the solvent-mediated nonoriented self-aggregation transformation in other solvents, which is proposed for the first time. On account of the low water activity and solubility, there is a self-cleaving phenomenon caused by the dehydration in the form I particles, and then the unstable phase transforms into form II, but the growth of the stable form is confined by the size and shape of the initial metastable particle and the products are aggregates. These aggregates with a well-defined shape and size have good performance in the dissolution rate with improved bioavailability.
引用
收藏
页码:4207 / 4216
页数:10
相关论文
共 41 条
[1]   On the Track of New Multicomponent Gabapentin Crystal Forms: Synthon Competition and pH Stability [J].
Andre, Vania ;
Fernandes, Auguste ;
Santos, Pedro Paulo ;
Duarte, M. Teresa .
CRYSTAL GROWTH & DESIGN, 2011, 11 (06) :2325-2334
[2]   An ester derivative of the drug gabapentin: pH dependent crystal stability [J].
Andre, Vania ;
Marques, M. Matilde ;
Minas da Piedade, M. F. ;
Duarte, M. Teresa .
JOURNAL OF MOLECULAR STRUCTURE, 2010, 973 (1-3) :173-179
[3]   Investigations of spherulitic growth in industrial crystallization [J].
Andreassen, Jens-Petter ;
Flaten, Ellen Marie ;
Beck, Ralf ;
Lewis, Alison Emslie .
CHEMICAL ENGINEERING RESEARCH & DESIGN, 2010, 88 (9A) :1163-1168
[4]   Spherulitic Growth of Calcium Carbonate [J].
Beck, Ralf ;
Andreassen, Jens-Petter .
CRYSTAL GROWTH & DESIGN, 2010, 10 (07) :2934-2947
[5]   The reluctant polymorph: investigation into the effect of self-association on the solvent mediated phase transformation and nucleation of theophylline [J].
Bobrovs, Raitis ;
Seton, Linda ;
Dempster, Nicola .
CRYSTENGCOMM, 2015, 17 (28) :5237-5251
[6]   Solvent-mediated phase transformation between two tegafur polymorphs in several solvents [J].
Bobrovs, Raitis ;
Seton, Linda ;
Actins, Andris .
CRYSTENGCOMM, 2014, 16 (46) :10581-10591
[7]   The growing world of crystal forms [J].
Braga, Dario ;
Grepioni, Fabrizia ;
Maini, Lucia .
CHEMICAL COMMUNICATIONS, 2010, 46 (34) :6232-6242
[8]   Polymorphic gabapentin: thermal behaviour, reactivity and interconversion of forms in solution and solid-state [J].
Braga, Dario ;
Grepioni, Fabrizia ;
Maini, Lucia ;
Rubini, Katia ;
Polito, Marco ;
Brescello, Roberto ;
Cotarca, Livius ;
Duarte, M. Teresa ;
Andre, Vania ;
Piedade, M. Fatima M. .
NEW JOURNAL OF CHEMISTRY, 2008, 32 (10) :1788-1795
[9]   Imaging molecular crystal polymorphs and their polycrystalline microstructures in situ by ultralow-frequency Raman spectroscopy [J].
Chang, Chun-Fu ;
Okajima, Hajime ;
Hamaguchi, Hiro-o ;
Shigeto, Shinsuke .
CHEMICAL COMMUNICATIONS, 2014, 50 (85) :12973-12976
[10]  
Dokoumetzidis A, 2006, PHARM RES-DORDR, V23, P256, DOI 10.1007/s11095-006-9093-3